Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
skip to main content
10.1145/3641142.3641172acmotherconferencesArticle/Chapter ViewAbstractPublication PagesacswConference Proceedingsconference-collections
research-article
Open access

Clinical Translation of a Heparin-Induced Thrombocytopenia predictor for Intensive Care Patients

Published: 13 May 2024 Publication History

Abstract

The emergence of novel digital data capture and analysis tools has vastly expanded the methods available to diagnose diseases at earlier stages or even predict their future appearance. Heparin-Induced Thrombocytopenia (HIT) is a as an adverse drug reaction to heparin, a frequently used anticoagulant. Accurate and prompt diagnosis of HIT is important to guide appropriate treatment strategies to avoid thromboembolic complications. This paper presents a machine learning-based HIT classifier, which can be used to predict HIT in intensive care patients. We used MIMIC-IV to develop a Light Gradient Boosting Machine learning model. The model yielded a Mathews Correlation Coefficient of 0.38 and 0.33 for the blind test and 10-fold Cross validation test respectively. The positive and negative likelihood ratios were 13.19 and 0.74 respectively, establishing that a positive test will signal an increased risk of HIT, whereas a negative test will not significantly modify the post-test probability, meaning that patient can follow usual care.

Supplemental Material

PDF File
Supplementary file

References

[1]
[n. d.]. Medical Information Mart for Intensive Care. https://mimic.mit.edu/ [Accessed: 2023-03-15].
[2]
[n. d.]. scikit-learn Machine Learning in Python. https://scikit-learn.org/stable/.
[3]
I Ahmed, A Majeed, and R Powell. 2007. Heparin induced thrombocytopenia: diagnosis and management update. Postgraduate medical journal 83, 983 (2007), 575–582.
[4]
Tom Bartol. 2015. Thoughtful use of diagnostic testing: Making practical sense of sensitivity, specificity, and predictive value. The Nurse Practitioner 40, 8 (2015), 10–12.
[5]
Maryam Bayat, Francisco Yuri B Macedo, Ahmed S Ansari, Arthur W Bracey, Samuel Akinyele, and Miguel Salazar. 2015. Evaluation of clinical and laboratory data for early diagnosis of heparin-induced thrombocytopenia. American Journal of Health-System Pharmacy 72, 19 (2015), 1649–1655.
[6]
Elijah Bolin and Wilson Lam. 2013. A review of sensitivity, specificity, and likelihood ratios: evaluating the utility of the electrocardiogram as a screening tool in hypertrophic cardiomyopathy. Congenital Heart Disease 8, 5 (2013), 406–410.
[7]
Jason Brownlee. 2021. SMOTE for Imbalanced Classification with Python. https://machinelearningmastery.com/smote-oversampling-for-imbalanced-classification/ [Accessed: 2023-03-15].
[8]
Daniel Capurro, Simon Coghlan, and Douglas EV Pires. 2022. Preventing digital overdiagnosis. JAMA 327, 6 (2022), 525–526.
[9]
Davide Chicco, Niklas Tötsch, and Giuseppe Jurman. 2021. The Matthews correlation coefficient (MCC) is more reliable than balanced accuracy, bookmaker informedness, and markedness in two-class confusion matrix evaluation. BioData mining 14, 1 (2021), 1–22.
[10]
Adam Cuker, Gowthami M Arepally, Beng H Chong, Douglas B Cines, Andreas Greinacher, Yves Gruel, Lori A Linkins, Stephen B Rodner, Sixten Selleng, Theodore E Warkentin, 2018. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood advances 2, 22 (2018), 3360–3392.
[11]
Adam Cuker, Phyllis A Gimotty, Mark A Crowther, and Theodore E Warkentin. 2012. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood, The Journal of the American Society of Hematology 120, 20 (2012), 4160–4167.
[12]
AL Goldberger, L Amaral, L Glass, JM Hausdorff, PC Ivanov, RG Mark, JE Mietus, GB Moody, CK Peng, and HE Stanley. 1997. Physiobank, physiotoolkit, and physionet: Circulation. Discovery 101, 23 (1997), 1.
[13]
Zhen Hu, Genevieve B Melton, Elliot G Arsoniadis, Yan Wang, Mary R Kwaan, and Gyorgy J Simon. 2017. Strategies for handling missing clinical data for automated surgical site infection detection from the electronic health record. Journal of biomedical informatics 68 (2017), 112–120.
[14]
Roman Jaeschke, Gordon H Guyatt, David L Sackett, Gordon Guyatt, Eric Bass, Patrick Brill-Edwards, George Browman, Deborah Cook, Michael Farkouh, Hertzel Gerstein, 1994. Users’ guides to the medical literature: III. How to use an article about a diagnostic test B. What are the results and will they help me in caring for my patients?Jama 271, 9 (1994), 703–707.
[15]
Joanne Joseph, David Rabbolini, Anoop K Enjeti, Emmanuel Favaloro, Marie-Christine Kopp, Simon McRae, Leonardo Pasalic, Chee Wee Tan, Christopher M Ward, and Beng H Chong. 2019. Diagnosis and management of heparin-induced thrombocytopenia: a consensus statement from the Thrombosis and Haemostasis Society of Australia and New Zealand HIT Writing Group. Medical Journal of Australia 210, 11 (2019), 509–516.
[16]
John G Kelton and Theodore E Warkentin. 2008. Heparin-induced thrombocytopenia: a historical perspective. Blood 112, 7 (2008), 2607.
[17]
Shawn J Kram, Arzo Hamidi, Bridgette L Kram, Gowthami Arepally, and Jerrold H Levy. 2022. The predictive value of the 4Ts and HEP score at recommended cutoffs in patients with mechanical circulatory support devices. Journal of Cardiothoracic and Vascular Anesthesia 36, 7 (2022), 1873–1879.
[18]
Lori-Ann Linkins, Antonio L Dans, Lisa K Moores, Robert Bona, Bruce L Davidson, Sam Schulman, and Mark Crowther. 2012. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141, 2 (2012), e495S–e530S.
[19]
Matteo Marchetti, Maxime G Zermatten, Debora Bertaggia Calderara, Alessandro Aliotta, and Lorenzo Alberio. 2021. Heparin-induced thrombocytopenia: a review of new concepts in pathogenesis, diagnosis, and management. Journal of Clinical Medicine 10, 4 (2021), 683.
[20]
Nadine Martel, James Lee, and Philip S Wells. 2005. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 106, 8 (2005), 2710–2715.
[21]
Henning Nilius, Adam Cuker, Sigve Haug, Christos Nakas, Jan-Dirk Studt, Dimitrios A Tsakiris, Andreas Greinacher, Adriana Mendez, Adrian Schmidt, Walter A Wuillemin, 2023. A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational study. EClinicalMedicine 55 (2023), 101745.
[22]
Rajul Parikh, Shefali Parikh, Ellen Arun, and Ravi Thomas. 2009. Likelihood ratios: clinical application in day-to-day practice. Indian journal of ophthalmology 57, 3 (2009), 217.
[23]
Allyson Pishko and Mark Crowther. 2023. Clinical presentation and diagnosis of heparin-induced thrombocytopenia. https://www.uptodate.com/contents/clinical-presentation-and-diagnosis-of-heparin-induced-thrombocytopenia [Accessed: 2023-03-15].
[24]
Jacob Shreffler and Martin R Huecker. 2020. Diagnostic testing accuracy: Sensitivity, specificity, predictive values and likelihood ratios. (2020).
[25]
Theodore E Warkentin and John G Kelton. 2001. Temporal aspects of heparin-induced thrombocytopenia. New England Journal of Medicine 344, 17 (2001), 1286–1292.
[26]
Robert W Yeh, Brendan M Everett, Shi-Yin Foo, David J Dorer, Michael Laposata, Elizabeth M Van Cott, and Ik-Kyung Jang. 2006. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization. The American journal of cardiology 98, 3 (2006), 419–421.

Index Terms

  1. Clinical Translation of a Heparin-Induced Thrombocytopenia predictor for Intensive Care Patients

    Recommendations

    Comments

    Information & Contributors

    Information

    Published In

    cover image ACM Other conferences
    ACSW '24: Proceedings of the 2024 Australasian Computer Science Week
    January 2024
    152 pages
    ISBN:9798400717307
    DOI:10.1145/3641142
    Permission to make digital or hard copies of part or all of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for third-party components of this work must be honored. For all other uses, contact the Owner/Author.

    Publisher

    Association for Computing Machinery

    New York, NY, United States

    Publication History

    Published: 13 May 2024

    Check for updates

    Author Tags

    1. Electronic Medical Records
    2. Heparin induced Throbocytopenia
    3. Light Gradient Boosting Machine
    4. Likelihood ratios
    5. Matthew Correlation Coefficient
    6. phenotypes

    Qualifiers

    • Research-article
    • Research
    • Refereed limited

    Data Availability

    Conference

    ACSW 2024
    ACSW 2024: 2024 Australasian Computer Science Week
    January 29 - February 2, 2024
    NSW, Sydney, Australia

    Acceptance Rates

    Overall Acceptance Rate 61 of 141 submissions, 43%

    Contributors

    Other Metrics

    Bibliometrics & Citations

    Bibliometrics

    Article Metrics

    • 0
      Total Citations
    • 155
      Total Downloads
    • Downloads (Last 12 months)155
    • Downloads (Last 6 weeks)25
    Reflects downloads up to 17 Feb 2025

    Other Metrics

    Citations

    View Options

    View options

    PDF

    View or Download as a PDF file.

    PDF

    eReader

    View online with eReader.

    eReader

    HTML Format

    View this article in HTML Format.

    HTML Format

    Login options

    Figures

    Tables

    Media

    Share

    Share

    Share this Publication link

    Share on social media